• RTI Surgical (Alachua, Florida) reported the first human implantation of the company's map3 Cellular Allogeneic Bone Graft implant was completed last week. RTI says the Map3 cellular allogeneic bone graft is a natural and safe alternative to autograft. Map3 provides a streamlined approach to bone grafting and supplies the three elements necessary for bone repair – osteogenesis, osteoinduction and osteoconduction – in a single allograft. Map3 uses multipotent adult progenitor cell-based (MAPC-based) technology with stem cells isolated from the same donor as the other bone material. RTI Surgical is a surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to advancing science, safety and innovation, RTI's implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in nearly 50 countries.

• Vidacare (San Antonio) is launching the T.A.L.O.N. (Tactically Advanced Lifesaving Intraosseous Needle) Intraosseous Vascular Access System for military use. The T.A.L.O.N. system is a single needle solution for vascular access that provides combat life savers and medics with rapid and accurate manual IO access to seven FDA cleared IO sites – proximal tibia (below the knee), distal tibia (ankle), proximal humerus (shoulder) and the sternum. The T.A.L.O.N. system is the first IO system to meet all Committee on Tactical Casualty Care (CoTCC) recommendations for IO devices. T.A.L.O.N. provides vascular access through the intraosseous (inside the bone) space and helps deliver vital fluids and drugs through this space, the body's largest non-collapsible vein, to injured soldiers safely and quickly. This system is designed to provide battlefield responders

No Comments